Scientists developed a miniature gas sensor for mobile devices
21 February 2017 | By Niamh Marriott, Digital Editor
VTT Technical Research Centre of Finland has developed a miniature gas sensor that can be connected to mobile devices.
List view / Grid view
News
Paresthesias nerve problems linked to World Trade Centre toxic dust
21 February 2017 | By Niamh Marriott, Digital Editor
A new study has tied the World Trade Centre (WTC) site with paresthesias, a nerve-related issue causing burning or prickling sensations...
Sustainable development indicators – can statistical indicators transform from back mirrors into drivers of change?
20 February 2017 | By Johanna Laiho-Kauranne, Director of Statistics, Luke
Johanna Laiho-Kauranne examines the 17 UN sustainable development goals that have been implemented for monitoring sustainability development...
Malaria control efforts can benefit from forecasting using satellites
20 February 2017 | By Niamh Marriott, Digital Editor
Umeå University researches have established links between patterns of malaria in Kenya and environmental factors measurable by satellite imagery...
Celltrion Healthcare & Pfizer’s biosimilar shows positive results in Crohn’s disease study
20 February 2017 | By Niamh Marriott, Digital Editor
Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar infliximab) in Crohn’s disease.
Custom to build £20 million Pharmaceutical Innovation Centre in Brighton
17 February 2017 | By Niamh Marriott, Digital Editor
Custom Pharma Services, the Brighton based CDMO, is pleased to announce the commencement of the building work on its £20 million Pharmaceutical Innovation Centre (PIC) in Moulsecoomb, Brighton. The Custom PIC will house the contract development, clinical and commercial manufacturing teams in a new, purpose built facility. This investment is…
FDA to review Mylan and Biocon’s biosimilar application
17 February 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has accepted Mylan and Biocon's biologics license application for MYL-1401H, a proposed biosimilar to Neulasta...
FDA approves new psoriasis drug that induced suicide in trial
17 February 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has approved Valeant’s Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Siliq is intended for patients who are candidates for systemic therapy (treatment using substances that travel through the bloodstream, after being taken by mouth or…
A novel and intuitive operating concept revolutionises Raman imaging
16 February 2017 | By WITec
WITec presents a new operating concept with the powerful and intuitive Suite FIVE at Pittcon 2017...
EC approves Eli Lilly’s rheumatoid arthritis drug
16 February 2017 | By Niamh Marriott, Digital Editor
The European Commission has granted marketing authorisation for Eli Lilly and Incyte’s baricitinib (Olumiant) for the treatment of moderate to severe active rheumatoid arthritis (RA), in adult patients who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs).
NICE does not recommend AbbVie’s leukaemia drug
16 February 2017 | By Niamh Marriott, Digital Editor
The incremental cost-effectiveness ratios (ICERs) for venetoclax compared with best supportive care were higher than the normally range...
SOPHiA AI becomes the technology of choice for clinical diagnostic in Latin America
16 February 2017 | By Niamh Marriott, Digital Editor
Sophia Genetics announced that ten new genomic institutions from Latin America have started using SOPHiA to democratise access to clinical genomics...
NICE approves Incyte’s leukaemia drug for routine NHS use
13 February 2017 | By Niamh Marriott, Digital Editor
NICE published draft guidance recommending ponatinib (Iclusig, Incyte Corporation) for routine use on the NHS, to treat chronic myeloid leukaemia...
1000 patient Phase III study required for Armetheon before FDA approval
10 February 2017 | By Niamh Marriott, Digital Editor
Armetheon has reached agreement with the FDA for a single 1000 patient final pivotal trial for its drug candidate, tecarfarin, prior to filing an NDA...
Amgen vs. Sanofi – appeals court suspend patent injunction
9 February 2017 | By Niamh Marriott, Digital Editor
"It is our longstanding position that Amgen's asserted patent claims are invalid and we look forward to moving forward with the appeal process."
